Novo Halves Ozempic Price to $499 a Month for Cash Customers (2)

Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for high US drug prices.

Patients can now get Ozempic for $499 a month — about half of its US list price — through Novo’s cash-pay pharmacy NovoCare, the company said in a statement Monday. It’s also partnering with GoodRx Holdings Inc. to offer Ozempic and its sister weight-loss drug Wegovy for the same price at pharmacies across the US.

President Donald Trump has been putting pressure on pharmaceutical companies to lower prices, including sending letters to drugmakers like Novo ...